VLC
DXCM icon

Van Leeuwen & Company’s DexCom DXCM Stock Holding History

Van Leeuwen & Company’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,579
Closed -$1.98M – 82
2023
Q2 		$1.98M Buy
+15,579
New +$1.88M 1.24% 27
2020
Q3 		– Sell
-3,348
Closed -$339K – 66
2020
Q2 		$339K Buy
+3,348
New +$299K 0.26% 54

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Van Leeuwen & Company's DXCM Position: Q3 2023 in Review

Van Leeuwen & Company sold out of DexCom (DXCM) in Q3 2023, closing a stake of 15,579 shares — an estimated $1.98M sold.

Van Leeuwen & Company first reported a position in DXCM in Q2 2020 and held it in 2 quarters. The position peaked at $1.98M in Q2 2023. 904 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Van Leeuwen & Company reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Van Leeuwen & Company sold 15,579 DexCom shares in Q3 2023, an estimated $1.98M.
  • Van Leeuwen & Company first reported a position in DexCom in Q2 2020 and held it in 2 quarters.
  • Van Leeuwen & Company's DexCom position peaked at $1.98M in Q2 2023.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Van Leeuwen & Company's 13F filing for Q3 2023, filed 9 Nov 2023.